Medra

Medra

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.medra.ai

Last Round

Series A

Dec 11, 2025

Total Funding Raised

$63M

Momentum Score

25 /100

Company Overview

Medra is a developer of robotic systems designed to automate laboratory tasks and accelerate biological research. The company's platform utilizes artificial intelligence, computer vision, and natural language processing to build systems that can handle repetitive work such as pipetting and loading biological samples. This automation allows scientists to focus on experimental design and analysis, with the goal of increasing the scale and precision of life science data collection. The company was founded by a team with experience from technology companies including Tesla, Amazon, SpaceX, and Neuralink. Medra is backed by several venture capital firms and participated in an accelerator program in late 2023.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Industrial Robotics, ML Platforms

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

lab automationAI lab automationwet lab automationself-driving labdrug discovery platformAI for drug discoveryrobotic workcellsclosed-loop systemautonomous scienceautomated experimentsbiotech equipmentPhysical AIScientific AIantibody designgene therapy development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medra Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Medra Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 11, 2025
SeedSep 12, 2025
AcceleratorDec 5, 2023

Key People

Founding team and executive leadership

Michelle Lee

CEO

Executive Team

Mitch Morando

COO

Executive Team

Medra Investors

Notable investors and investment history

InvestorRounds
Human CapitalSeries A
NeoSeries A, Seed
Fusion FundSeries A
PharmStarsAccelerator
Lux CapitalSeries A, Seed
Seven Seven SixSeries A
Catalio Capital ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    $52M Series A round completed.

  • Dec 11, 2025

    Partnered with Genentech to advance research.

Medra Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Medra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Medra's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range31
Year Founded2021
Last FundingDec 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.